Shenzhen YHLO Biotech Co., Ltd. announced Annual dividend of CNY 0.2100 per share payable on June 27, 2025, ex-date on June 27, 2025 and record date on June 26, 2025.
Shenzhen YHLO Biotech Co Ltd is a China-based company primarily engaged in the provision of in vitro diagnostic instruments. The Company mainly focuses on the research, development, production, and sales of in vitro diagnostic instruments and related reagents based on chemiluminescence immunoassay, as well as the agency sales of some non-self-produced medical device products. The Company's products are used in fields such as autoimmunity, reproductive health, diabetes, and infectious diseases. The Company's products are sold in domestic and international markets.
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
